Overview

A Trial of Hetrombopag in Healthy Subjects

Status:
Completed

Trial end date:
2020-10-22

Target enrollment:

Participant gender:

Summary

This is a single-center, single-arm, open-label, self-controlled, phase I clinical study. A total of 26 male or female healthy subjects are intended to be enrolled to evaluate the PK drug-drug interaction between ciclosporin and hetrombopag.

Phase:

Phase 1

Details

Lead Sponsor:

Jiangsu HengRui Medicine Co., Ltd.

Treatments:

Cyclosporine
Cyclosporins